IMPACT BIOMEDICAL INC. (IBO) Cash Flow Statement
IMPACT BIOMEDICAL INC. (IBO) generated -$508000 of operating cash flow over the twelve months to 2026-06-30, spent $0 on capital expenditure and had free cash flow of -$508000, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IBOIMPACT BIOMEDICAL INC.Follow IBO — free
—
Price chart with a free account
- Market cap
- 30.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 6 Nov, in 13 days
| Line | FY2022 Dec 22 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating cash flow | — | -1.9 | -0.5 | |
| Capital expenditure | — | 0.0 | -0.0 | |
| Free cash flow | — | -1.9 | -0.5 | |
| Stock-based compensation | — | 0.0 | — |
USD millions · SEC XBRL
IMPACT BIOMEDICAL INC. — questions
- What is IMPACT BIOMEDICAL INC.'s operating cash flow?
- -$508000 over the twelve months to 2026-06-30.
- How much does IMPACT BIOMEDICAL INC. spend on capital expenditure?
- $0 over the twelve months to 2026-06-30.
- What is IMPACT BIOMEDICAL INC.'s free cash flow?
- -$508000 over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from IMPACT BIOMEDICAL INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.